Defining Biological and Clinical Plausibility: The DICSA Framework for Protocolized Assessment in Survival Extrapolations Across Therapeutic Areas.
Saved in:
| Title: | Defining Biological and Clinical Plausibility: The DICSA Framework for Protocolized Assessment in Survival Extrapolations Across Therapeutic Areas. |
|---|---|
| Authors: | Heeg B; Cytel, 3012 NJ, Rotterdam, The Netherlands. bart.heeg@cytel.com., Lee D; University of Exeter Medical School, South Cloisters, St Luke's Campus, Exeter, EX1 2LU, UK., Adam J; St George'S Hospital, Blackshaw Road, London, SW17 0QT, UK., Postma M; Unit of Global Health, Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.; Department of Economics, Econometrics and Finance, Faculty of Economics and Business, Groningen, University of Groningen, The Netherlands Nettelbosje 2, 9747 AE, Groningen, The Netherlands.; Center of Excellence for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia.; Division of Pharmacology and Therapy, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia., Ouwens M; Real World Science and Analytics, Astrazeneca Global, Västergötland, Sweden. |
| Source: | PharmacoEconomics [Pharmacoeconomics] 2025 Jul; Vol. 43 (7), pp. 793-803. Date of Electronic Publication: 2025 Mar 29. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1179-2027 |
|---|---|
| DOI: | 10.1007/s40273-025-01485-0 |
